.
Widespread pain, fatigue, and sleep disturbance — a real, diagnosable, and treatable condition
Fibromyalgia is a complex central sensitisation syndrome characterised by widespread musculoskeletal pain, fatigue, sleep disturbance, cognitive difficulties ('fibro fog'), and heightened pain sensitivity. It affects 2–8% of the global population, predominantly women aged 30–60.
Although not primarily a structural musculoskeletal disorder, it has significant overlap with myofascial pain and is best managed through a multidisciplinary approach including pharmacological, interventional, and rehabilitative strategies.
Our interventional pain specialists offer the following evidence-based procedures, all performed with real-time ultrasound guidance for precision and safety:
The revised 2016 ACR diagnostic criteria have improved recognition of fibromyalgia. The emerging concept of nociplastic pain — pain arising from altered nociception without tissue damage — encompasses fibromyalgia and guides the shift toward central sensitisation-targeted treatments rather than structural interventions.